Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › OR › Beaverton › NPI 1073054714

University Professional Services

University Professional Services was paid $8.13M by Medicaid between Apr 2018 and Dec 2024, across 22 billing codes. Its largest line is J1569, Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg — 41% of everything it billed.

33Billing provider infoUNIVERSITY PROFESSIONAL SERVICES
BEAVERTON, OR 97008
33aNPI1073054714assigned 03/14/2017
33bProvider typeRegistered Nurse
28Total paid$8.13M
24GClaims36,092
24DCodes billed22
24AFirst – last monthApr 2018 – Dec 2024
Compared with peers

Next to other Registered Nurse providers in Oregon

Rank by total paid#1 of 34
Median peer was paid$11K
This provider vs. median765×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official SMITH, KELLY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$100K$200K$300K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018381$18K
20191,125$70K
20204,447$612K
20215,962$1.07M
20227,003$1.94M
20238,969$2.48M
2024incomplete8,205$1.94M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg 41% 1,669 537 $3.37M
Q5103 Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg 26% 1,511 1,283 $2.08M
J1745 Injection, infliximab, excludes biosimilar, 10 mg 11% 414 329 $919K
99601 8.1% 12,555 7,315 $656K
99602 Nursing care in home rn 4.7% 6,238 4,131 $382K
S9338 Home infusion therapy, immunotherapy, administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem 4.2% 2,482 1,763 $340K
S9359 Home infusion therapy, anti-tumor necrosis factor intravenous therapy; (e.g., infliximab); administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem 2.2% 2,046 1,920 $180K
S9379 Home infusion therapy, infusion therapy, not otherwise classified; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem <1% 1,440 599 $65K
S9542 Home injectable therapy, not otherwise classified, including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem <1% 755 232 $56K
S9500 Home infusion therapy, antibiotic, antiviral, or antifungal therapy; once every 24 hours; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem <1% 48 12 $21K
Q5119 Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg <1% 13 12 $20K
J3490 Unclassified drugs <1% 472 176 $10K
10 more codes
S9357 Home infusion therapy, enzyme replacement intravenous therapy; (e.g., imiglucerase); administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem <1% 63 $10K
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 1,096 $7K
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 3,294 $5K
S9374 Home infusion therapy, hydration therapy; one liter per day, administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem <1% 32 $4K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 236 $2K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 1,270 $2K
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 187 $2K
S9494 Home infusion therapy, antibiotic, antiviral, or antifungal therapy; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem (do not use this code with home infusion codes for hourly dosing schedules s9497-s9504) <1% 75 $1K
A4221 Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately) <1% 49 $399.25
J7050 Infusion, normal saline solution, 250 cc <1% 147 $109.59

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSMITH, KELLY (VICE PRESIDENT, ERC)
Parent organizationUNIVERSITY PROFESSIONAL SERVICES
Same official

Other billing entities under SMITH, KELLY

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.